An 'activatable' aptamer-based fluorescence probe for the detection of HepG2 cells

Zongqiang Lai1, Juntao Tan1, Ruirong Wan1

  • 1National Center for International Research of Biological Targeting Diagnosis and Therapy, Guangxi Key Laboratory of Biological Targeting Diagnosis and Therapy Research, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.

Oncology Reports
|March 25, 2017
PubMed
Summary

A new activatable aptamer-based fluorescence probe (AAFP) offers sensitive and specific cancer cell detection. This probe shows minimal fluorescence without cancer cells but a strong signal in their presence, aiding cancer diagnosis.